{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:58:36Z","timestamp":1785859116567,"version":"3.56.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1097\/01.ftd.0000192135.54477.d9","type":"journal-article","created":{"date-parts":[[2006,1,17]],"date-time":"2006-01-17T05:16:13Z","timestamp":1137474973000},"page":"12-13","source":"Crossref","is-referenced-by-count":10,"title":["Therapeutic Drug Monitoring of Antithyroid Drugs in Pregnancy"],"prefix":"10.1097","volume":"28","author":[{"given":"Gideon","family":"Koren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Offie","family":"Soldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/0002-9378(89)90186-5","article-title":"Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester.","volume":"160","author":"Koren","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1749-6632.1993.tb26134.x","article-title":"How women perceive teratogenic risk and what they do about it.","volume":"678","author":"Koren","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/jcp.2004.021881","article-title":"Screening for thyroid disease in pregnancy.","volume":"58","author":"Lazarus","year":"2005","journal-title":"J Clin Pathol"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1507\/endocrj.44.581","article-title":"Triphasic changes in thyroid function in a patient with primary hypothyroidism in the course of pregnancy and the early post-partum period.","volume":"44","author":"Ohguni","year":"1997","journal-title":"Endocr J"},{"key":"R5-5-20210129","first-page":"3099","article-title":"Methimazole and propylthiouracil equally cross the perfused human term placental lobule.","volume":"82","author":"Mortimer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1210\/jcem-62-1-217","article-title":"Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests.","volume":"62","author":"Gardner","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-5-20210129","first-page":"3633","article-title":"Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves hyperthyroidism.","volume":"82","author":"Momotani","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/tera.1072","article-title":"Adverse effects of prenatal methimazole exposure.","volume":"64","author":"Di Gianantonio","year":"2001","journal-title":"Teratology"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-3806(03)00191-3","article-title":"Propylthiouracil (PTU)-induced hypothyroidism in the developing rat impairs synaptic transmission and plasticity in the dentate gyrus of the adult hippocampus.","volume":"145","author":"Gilbert","year":"2003","journal-title":"Brain Res Dev Brain Res"},{"key":"R10-5-20210129","first-page":"282","article-title":"Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole.","volume":"46","author":"Mujtaba","year":"1975","journal-title":"Obstet Gynecol"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/BF03345080","article-title":"Thyroid function and intellectual development of children of mothers taking methimazole during pregnancy.","volume":"25","author":"Azizi","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2265.2000.01078.x","article-title":"Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil.","volume":"53","author":"Momotani","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1542\/peds.106.1.27","article-title":"Choice of breastfeeding and physicians advice: a cohort study of women receiving propylthiouracil.","volume":"106","author":"Lee","year":"2000","journal-title":"Pediatrics"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.ftd.0000192135.54477.d9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:05:32Z","timestamp":1785855932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200602000-00005"}},"subtitle":["The Knowledge Gaps"],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ftd.0000192135.54477.d9","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}